AFP and hepatocellular carcinoma: Furthermore, we investigated whether the FasMab can be used for the detection of fucosylated AFP in sera of HCC patients using a preliminary High Sensitivity Chemiluminescence Enzyme Immunoassay (HISCL) kit.